Discontinued Operations Sale of Infusionz to Bloomios (Table)

3 Months Ended

Sep. 30, 2023

Discontinued Operations - Sale of Infusionz to Bloomios

Schedule Of inventory or working capital

Tangible assets, inventory / working capital*	$	(1,344,000	)
Tangible assets, warehouse and manufacturing equipment, net of accumulated depreciation*		(679,327	)
Goodwill		(2,413,814	)
Intangible assets, net of accumulated amortization		(946,996	)
Accrued and incurred expenses related to the transaction and additional working capital*		(2,051,500	)
Consideration received, including cash, debt and equity, net		15,000,000
Total gain recognized	$	7,564,363

Schedule Of Sale of Infusionz to Bloomios

Advance for payroll	$	50,000
Operating expense		652,891
Management fees		685,600
Excess working capital		388,565
Accrued Interest		247,885
Subtotal due from Bloomios	$	2,024,941
Reserve		1,179,498
Total due from Bloomios	$	845,443

Schedule Of Investments - Bloomios

Inventory	$	1,090,828
Accounts receivable		157,200
Accounts payable and accrued liabilities		(475,817	)
Customer deposits		(133,950	)
Fixed assets		208,182
Net assets	$	845,443
Due from Bloomios	$	-

Schedule Of Discontinued Operations

	Three months ended September 30,
	2023			2022
Discontinued Operations
Revenue	$	158,147		$	955,762
Cost of sales	$	11,982		$	730,306
Sales, general and administrative expenses	$	339,205		$	663,778
Depreciation and amortization	$	-		$	9,795
Income (loss) from discontinued operations	$	(193,040	)	$	(448,117	)
Accounts receivable net of allowance for doubtful accounts	$	-		$	35,482
Fixed assets, net of accumulated depreciation	$	-		$	5,195
Total assets	$	-		$	321,425
Total liabilities	$	-		$	652,911